Pavlina Spiliopoulou

11PUBLICATIONS
57CO-AUTHORS
Predictive and prognostic markersMolecular targetsGene and molecular therapyCancer geneticsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Aug 13, 2026
Immune checkpoint blockade sensitivity is linked to endogenous retroelement transcriptional changes in cancer.

|May 14, 2025
Oncogenic Signalling Pathways in Cancer Immunotherapy: Leader or Follower in This Delicate Dance?

Douglas Cartwright, Andrew C Kidd, Sonam Ansel

|Aug 26, 2024
PTEN Loss Shapes Macrophage Dynamics in High-Grade Serous Ovarian Carcinoma.

Sarah Spear, Olivia Le Saux, Hasan B Mirza

|Jan 11, 2024
Promising and Minimally Invasive Biomarkers: Targeting Melanoma.

Pavlina Spiliopoulou, Carlos Diego Holanda Lopes, Anna Spreafico

|Nov 28, 2023
Circulating Oncometabolite 2-hydroxyglutarate as a Potential Biomarker for Isocitrate Dehydrogenase (IDH1/2) Mutant Cholangiocarcinoma.

Cha Len Lee, Grainne M O'Kane, Warren P Mason

|Mar 01, 2023
The role of cytoreductive nephrectomy and systemic therapy in the management of tumour thrombus in patients with metastatic renal cell carcinoma.

Abhenil Mittal, Esmail Al-Ezzi, Xuan Li

Pageof 2

Frequent Collaborators

3 joint publications

Anna Spreafico

2 joint publications

Aaron R Hansen

2 joint publications

Sarah Spear

2 joint publications

Hasan Mirza